LATEST NEWSRead more...

17

May 2024

A2 Bio Commences EVEREST-2 Phase 1 Clinical Trial with Initial Patient Administered Novel Mesothelin Logic-Gated CAR T Therapy

A Biotherapeutics Inc has initiated the Phase clinical trial for AB marking a significant milestone in the development of its innovative cell therapy This clinicalstage company specializes

17

May 2024

Accelerated Biosciences and Spanios Announce Partnership to Improve Therapeutic Approaches for Solid Tumor Cancers

Spanios a company known for its unique D tumoroid platforms used to validate solid tumor therapies has announced a new partnership with Accelerated Biosciences Accelerated Biosciences

16

May 2024

Aulos Bioscience Collaborates with Merck KGaA, Darmstadt, Germany for Joint Clinical Trial on Bavencio® and AU-007 Combination

Aulos Bioscience a company in immunooncology striving to transform cancer treatment with innovative IL therapeutics has announced a significant collaboration with Ares Trading SA a Swiss subsidiary

15

May 2024

Verismo Therapeutics Obtains FDA Clearance for SynKIR™-310 in Relapsed/Refractory B-cell NHL

Verismo Therapeutics has received approval from the US Food and Drug Administration to proceed with the Phase clinical trial of SynKIR for NHL This trial named CELESTIAL will evaluate the safety

15

May 2024

FogPharma and ARTBIO Announce Partnership for the Development of Multiple Helicon™-Enabled Alpha-Particle Radioligand Therapies in Cancer Treatment

FogPharma and ARTBIO Inc are collaborating to develop advanced therapies for various cancers FogPharma renowned for its innovative Helicon peptide platform and ARTBIO

14

May 2024

Walden Biosciences Announces Collaboration with Leading Genetic Epidemiologist to Investigate suPAR's Causal Role in Chronic Kidney Disease

Walden Biosciences Inc a biotechnology company focused on developing therapies for kidney disease has partnered with the Primula Group to utilize genetic data from individuals with chronic kidney disease

press releasesRead more...

Marinus Pharmaceuticals Announces Key Business Updates for Tuberous Sclerosis Complex Program

Marinus Pharmaceuticals Inc a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders today announced completion of enrollment in the global

FDA Approves IMDELLTRA™ (Tarlatamab-dlle), the First and Only T-cell Engager Therapy for the Treatment of Extensive-stage Small Cell Lung Cancer

Amgen today announced that the US Food and Drug Administration has approved IMDELLTRA for the treatment of adult patients with extensivestage small cell lung

Tourmaline Bio Initiates Clinical Development of TOUR006 for Cardiovascular Diseases with First Patient Dosed in Phase 2 TRANQUILITY Trial

Tourmaline Bio Inc a latestage clinical biotechnology company developing transformative medicines to dramatically improve the lives of patients

Moleculin Announces Commencement of NIH-Funded Phase 2 Clinical Trial of STAT3 Inhibitor for the Treatment of Glioblastoma (NU 21C06)

Moleculin Biotech Inc a clinicalstage pharmaceutical company with a broad portfolio of drug candidates targeting hardtotreat tumors and viruses today

EventsRead more...

20 - 22

May 2024

2nd Global Summit on Medicinal Chemistry and Drug

Prague, Czech Republic

20 - 21

May 2024

The 5th International Conference on CLINICAL

Budapest, Hungary

21 - 23

May 2024

15th Global Drug Delivery & Formulation Summit

Berlin, Germany

21 - 23

May 2024

Cytokine-Based Drug Development Summit

Boston, MA, USA

21 - 23

May 2024

6th Annual Cell Engager Summit

Boston, MA, USA

21 - 21

May 2024

Drug Discovery Biology & Bioinformatics

San Diego, USA

21 - 23

May 2024

3rd Annual ALS Drug Development Summit

Boston, MA, USA

21 - 22

May 2024

15th Annual Outsourcing in Clinical Trials

Pennsylvania, USA

Oliver Healthcare Packaging Pharmaceutical Solutions

ThermoFisher - Mastering API production at every scale

Sartorius Webinar - Pave Your Weigh to Accurate Analytical Results

KNOWLEDGE BANK

Articles
Pharma Safety in Sterile Fill-Finish: Ensuring Quality and Compliance
The sterile fillfinish process is the final step in pharmaceutical manufacturing before medications reach patients This process is particularly critical for injectable drugs because they bypass the bodys natural defense mechanisms
How Pharmacoepidemiology Drives Clinical Research: Exploring Trends and Insights
The pharmaceutical industry operates within a complex regulatory framework aimed at ensuring the safety efficacy and quality of medicinal products
Navigating Gene Therapy Regulations: Compliance Strategies for Successful Implementation
Gene therapy holds immense promise for treating a wide range of genetic disorders and diseases However its implementation requires strict adherence to regulatory guidelines to ensure safety efficacy and ethical considerations
Efficiency in Bioprocessing: Unveiling Upstream and Downstream Operations
Bioprocessing plays a crucial role in the pharmaceutical biotechnology and healthcare industries ensuring the efficient production of biologics vaccines and other biobased products
Digital Twins: The Future Blueprint for Pharmaceutical Production
Digital Twins have revolutionized the pharmaceutical industry by providing virtual replicas of physical assets and processes This innovative technology offers a comprehensive view of manufacturing
Revolutionizing Health: The Future of Gene Editing and Genetic Engineering
In the realm of healthcare few advancements hold as much promise and controversy as gene editing and genetic engineering These technologies once confined to science fiction are now tangible tools

Research Insights
Priority-Setting for Novel Drug Regimens to Treat Tuberculosis: An Epidemiologic Model
AbstractBackgroundNovel drug regimens are needed for tuberculosis TB treatment New regimens aim to improve on characteristics such as duration efficacy and safety profile but no single regimen is likely to be ideal in all respects By linking these regimen characteristics to a novel regimens ability

Techno Trends
UW–Madison School of Pharmacy Designs New Compounds to Fight Deadly Mosquito-Transmitted Viruses
UWMadison school of Pharmacy designed a breakthrough in creating new small molecules that penetrate into the brain where the virus resides and interfere with viral replication to stop Equine Encephalitis Viruses EEV

Advisory Board

Scott M. Wheelwright

Gustavo Samojeden

Juris Hmelnickis

Dmitrii Vitalievich Kriuchkov

Nigel Cryer FRSC

Hoda Gamal

Hassan Mostafa Mohamed

Teresa Derbiszewska

Paola Antonini

Amine Bekkali

Josipa Ljubicic

Joaquin D. Campbell

EDITORIAL SECTION

STRATEGY
Strategic Partnerships in Biotech
Biotechnology an industry at the forefront of scientific innovation and transformative healthcare solutions

RESEARCH DEVELOPMENT
unlock lab efficiencies and decision-making through a digital-first approach to lab transformation
Recent industry pressures brought on by the global COVID pandemic provided critical lessons for the life sciences industry

CLINICAL TRIALS
Bringing New Treatments to Patients with Rare Diseases
Today there are more than known rare diseases defined by the European Union as conditions that affect less than in people

MANUFACTURING
Advanced Pharmaceutical Continuous Manufacturing of Liquid Dosage Forms
Continuous manufacturing methods have been extensively demonstrated to have a significant impact on improving quality

Information Technology
Artificial Intelligence in Drug Manufacturing and Drug Discovery
In drug discovery AI is being used to predict the efficacy and safety of potential drug candidates identify new therapeutic targets and optimize clinical trial designs

EXPERT Talk
Global Drug Delivery and Formulation Summit
Currently Im VP of Advanced Drug Delivery at Novo Nordisk Much of my role focuses on understanding drug delivery needs across our Research Early Development portfolio and identifying novel technologies

Strategic Partnerships in Biotech

Why are Generic Pharmaceutical Manufacturers Leaving the USA?

Emerging role of Mass Spectrometry in Biologics Development

Unlock lab efficiencies and decision-making through a digitalfirst approach to lab transformation

Using AI to Accelerate Drug Discovery

Bringing New Treatments to Patients with Rare Diseases

Addressing the Unmet Needs in Respiratory Disease Treatment with Inhaled mRNA Medicines

GENOMIC MEDICINE KEEPS INNOVATING AND MANUFACTURING NEEDS TO KEEP PACE

Advanced Pharmaceutical Continuous Manufacturing of Liquid Dosage Forms

Safeguarding Sterility

Innovations in Pharmaceutical R&D: Navigating the Future.

LATEST NEWSRead more...

17

A2 Bio Commences EVEREST-2 Phase 1 Clinical Trial with Initial Patient Administered Novel Mesothelin Logic-Gated CAR T Therapy

17

Accelerated Biosciences and Spanios Announce Partnership to Improve Therapeutic Approaches for Solid Tumor Cancers

16

Aulos Bioscience Collaborates with Merck KGaA, Darmstadt, Germany for Joint Clinical Trial on Bavencio® and AU-007 Combination

15

Verismo Therapeutics Obtains FDA Clearance for SynKIR™-310 in Relapsed/Refractory B-cell NHL

15

FogPharma and ARTBIO Announce Partnership for the Development of Multiple Helicon™-Enabled Alpha-Particle Radioligand Therapies in Cancer Treatment

14

Walden Biosciences Announces Collaboration with Leading Genetic Epidemiologist to Investigate suPAR's Causal Role in Chronic Kidney Disease

press releasesRead more...

Marinus Pharmaceuticals Announces Key Business Updates for Tuberous Sclerosis Complex Program

FDA Approves IMDELLTRA™ (Tarlatamab-dlle), the First and Only T-cell Engager Therapy for the Treatment of Extensive-stage Small Cell Lung Cancer

Tourmaline Bio Initiates Clinical Development of TOUR006 for Cardiovascular Diseases with First Patient Dosed in Phase 2 TRANQUILITY Trial

Moleculin Announces Commencement of NIH-Funded Phase 2 Clinical Trial of STAT3 Inhibitor for the Treatment of Glioblastoma (NU 21C06)

EventsRead more...

20 - 22

2nd Global Summit on Medicinal Chemistry and Drug

20 - 21

The 5th International Conference on CLINICAL

21 - 23

15th Global Drug Delivery & Formulation Summit

21 - 23

Cytokine-Based Drug Development Summit

21 - 23

6th Annual Cell Engager Summit

21 - 21

Drug Discovery Biology & Bioinformatics

21 - 23

3rd Annual ALS Drug Development Summit

21 - 22

15th Annual Outsourcing in Clinical Trials

TOP ARTICLES

1

How Pharmacoepidemiology Drives Clinical Research: Exploring Trends and Insights

Kate Williamson

2

Navigating Gene Therapy Regulations: Compliance Strategies for Successful Implementation

Kate Williamson

3

Efficiency in Bioprocessing: Unveiling Upstream and Downstream Operations

Kate Williamson

4

Digital Twins: The Future Blueprint for Pharmaceutical Production

Kate Williamson

5

Revolutionizing Health: The Future of Gene Editing and Genetic Engineering

Kate Williamson

KNOWLEDGE BANK

Pharma Safety in Sterile Fill-Finish: Ensuring Quality and Compliance

How Pharmacoepidemiology Drives Clinical Research: Exploring Trends and Insights

Navigating Gene Therapy Regulations: Compliance Strategies for Successful Implementation

Efficiency in Bioprocessing: Unveiling Upstream and Downstream Operations

Digital Twins: The Future Blueprint for Pharmaceutical Production

Revolutionizing Health: The Future of Gene Editing and Genetic Engineering

Priority-Setting for Novel Drug Regimens to Treat Tuberculosis: An Epidemiologic Model

UW–Madison School of Pharmacy Designs New Compounds to Fight Deadly Mosquito-Transmitted Viruses

Advisory Board

EDITORIAL SECTION

Strategic Partnerships in Biotech

unlock lab efficiencies and decision-making through a digital-first approach to lab transformation

Bringing New Treatments to Patients with Rare Diseases

Advanced Pharmaceutical Continuous Manufacturing of Liquid Dosage Forms

Artificial Intelligence in Drug Manufacturing and Drug Discovery

Global Drug Delivery and Formulation Summit